MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3109/00365521.2012.690044

Медицинская библиотека · Scandinavian journal of gastroenterology · 2012

The role of glucocorticoids in sodium retention in cirrhotic patients: a double blind, randomized, crossover study.

Højmark Hansen Martin, Kristensen Steffen Skott, Schaffalitzky de Muckadell Ove B, Thiesson Helle Charlotte, Andrew Ruth, Dam Fialla Annette

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

Cirrhotic patients have an increased ratio of urinary cortisol to cortisone metabolites, indicating decreased renal 11-β-hydroxysteroid dehydrogenase type-2 activity. This suggests that cortisol--by activation of the mineralocorticoid receptor--may contribute to the abnormal sodium retention evident in cirrhosis. The aim was to elucidate the role of glucocorticoids in sodium retention in decompensated cirrhotic patients.

METHODS

A randomized, double-blind, placebo-controlled, crossover study was performed in nine patients with alcoholic cirrhosis of the liver. A washout interval of 14 days separated the two periods. After a basal period of 36 h, dexamethasone (0.5 mg every 6 h) or placebo was given for two days. Urine was collected for 12 h periods, and the concentrations of sodium, potassium, creatinine, cortisol and cortisol metabolites were determined. Blood samples for hemoglobin, glucose, sodium, potassium, creatinine, aldosterone and cortisol were obtained daily.

RESULTS

Dexamethasone treatment decreased S-cortisol 92.3% (82.9-93.4%) (median and range) compared with that in the basal period. Natriuresis (dexamethasone--placebo) increased 55.1 (-26.4-168.7) mmol/day (median and range). No statistically significant differences (dexamethasone--placebo) were found in changes in body weight (0.00 (-0.45-2.20) kg/day), diuresis (0.56 (-0.35-1.43) L/day) or mean arterial pressure (8.33 (-16.0-41.3) mmHg) (median and range) in reference to the preceding 24 h basal period.

CONCLUSION

These results indicate that endogenous glucocorticoids contribute to the sodium retention in patients with alcoholic cirrhosis of the liver.

Для цитирования: Højmark Hansen Martin, Kristensen Steffen Skott, Schaffalitzky de Muckadell Ove B, Thiesson Helle Charlotte, Andrew Ruth, Dam Fialla Annette. The role of glucocorticoids in sodium retention in cirrhotic patients: a double blind, randomized, crossover study.. Scandinavian journal of gastroenterology. 2012. DOI: 10.3109/00365521.2012.690044.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.